株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

非オピオイド鎮痛薬の世界市場:~2024年

Non-opioid Pain Treatment: Global Markets to 2024

発行 BCC Research 商品コード 606202
出版日 ページ情報 英文 165 Pages
即納可能
価格
本日の銀行送金レート: 1USD=111.19円で換算しております。
Back to Top
非オピオイド鎮痛薬の世界市場:~2024年 Non-opioid Pain Treatment: Global Markets to 2024
出版日: 2019年12月31日 ページ情報: 英文 165 Pages
概要

当レポートは、世界の非オピオイド鎮痛薬の市場を調査し、市場の定義と概要、疼痛および疼痛治療の経緯、市場成長への各種影響因子および市場機会の分析、疼痛治療の代替的非オピオイド療法の各種タイプ、製品区分・疾患区分・地域/主要国別の動向と市場規模の推移と予測、特許動向、主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 サマリー・ハイライト

  • 市場概要
  • 推進因子・障壁

第3章 市場概要・背景

  • 疼痛・侵害受容の定義
  • 疼痛・疼痛治療の歴史
  • 生理学的な痛みの分類
  • 疼痛の診断
  • 疼痛の治療
  • オピオイド vs 非オピオイド疼痛管理
  • 麻薬性鎮痛薬としても知られるオピオイド
  • フル&パーシャルアゴニスト
  • アゴニスト-アンタゴニスト
  • オピオイド疼痛治療のリスク・合併症
  • 疼痛管理の代替的手法
  • 代替的非オピオイド治療
    • 医療大麻
    • カプサイシン由来化合物
    • メントール含有化合物
    • オメガ3脂肪酸含有サプリメント
    • ボツリヌス毒素
    • その他
  • 大麻による疼痛治療の拡大
    • 医療大麻の導入:世界の分析
    • 法規制
    • 有効性
    • 力価試験・バリデーション試験
  • ホスピスケア
  • 緩和医療へのアクセス
  • 緩和医療ニーズの評価
  • 市場影響因子・成長指標
  • 人口動態概要
  • 疼痛を伴う症状の罹患率・有病率

第4章 市場分析・予測:製品区分別

  • 概要
  • 医療大麻
  • カプサイシン由来化合物
  • メントール含有化合物
  • オメガ3脂肪酸含有サプリメント
  • ボツリヌス毒素

第5章 市場分析・予測:疾患区分別

  • 概要
  • 癌性疼痛
  • 神経因性疼痛
  • 整形外科/筋骨格系疼痛
  • その他

第6章 市場分析・予測:地域・主要国別

  • 概要
  • 北米
  • 欧州・中東・アフリカ
  • アジア太平洋
  • ラテンアメリカ

第7章 特許分析

第8章 企業プロファイル

  • ALLERGAN PLC
  • APHRIA INC.
  • AURORA
  • BEDROCAN
  • CANOPY GROWTH CORP.
  • CARA THERAPEUTICS
  • CENTREXION THERAPEUTICS
  • CHT MEDICAL
  • CRONOS GROUP
  • GW PHARMACEUTICALS
  • MEDICAL MARIJUANA INC.
  • MEDROPHARM GMBH
  • PANAG PHARMA INC.
  • TILRAY
  • US WORLDMEDS LLC
  • VANWAY

第9章 付録:用語・情報ソース

図表

List of Tables

  • Table A: Major Countries, by Region
  • Summary Table: Global Market for Non-opioid Pain Treatments, by Product Segment, Through 2024
    • Table 1: Physiological Effects of Pain
    • Table 2: United States Opioid Addiction and Abuse Statistics
    • Table 3: Global Opioid Addiction and Abuse Statistics
    • Table 4: List of Brand Name Extended-release and Long-acting Opioid Products Required to be Included in Opioid REMS, May 2017
    • Table 5: List of Generic Extended-release and Long-acting Opioid Products Required to be Included in Opioid REMS, May 2017
    • Table 6: List of Transmucosal Immediate-release Fentanyl Products Required to be Included in the TIRF REMS Access Program
    • Table 7: Adoption of Medical Cannabis, by Country (Age 15 and Over), 2017
    • Table 8: Medical Cannabis Programs, by U.S. State, 1998-2017
    • Table 9: Top Five U.S. States with Medical Cannabis Applications/Registrations
    • Table 10: Effectiveness of Fibromyalgia Treatments: Cannabis vs. Pharmaceutical Therapies
    • Table 11: Hospice Statistics, Patient Characteristics, 2009-2014
    • Table 12: Hospice Statistics, Patients, by Primary Diagnosis, 2009-2014
    • Table 13: Global Population, by Country/Region, Through 2024
    • Table 14: Global Population, Age 65+, by Country/Region, Through 2024
    • Table 15: Global Life Expectancy at Birth, by Country/Region, 1980, 2010 and 2020 Projections (Both Genders Combined)
    • Table 16: Global Non-opioid Pain Treatment Market, by Product Segment, Through 2024
    • Table 17: Global Market Shares of Non-opioid Pain Treatments, by Product Segment, 2018
    • Table 18: Selected Cannabis Clinical Trials for Pain Treatment, Through Nov. 30, 2018
    • Table 19: Global Medical Cannabis Pain Treatment Market, by Indication, Through 2024
    • Table 20: Global Market Shares of Medical Cannabis Pain Treatments, by Indication, 2018
    • Table 21: Selected Capsaicin-derived Clinical Trials for Pain Treatment, Through Nov. 30, 2019
    • Table 22: Global Capsaicin-derived Pain Treatment Market, by Indication, Through 2024
    • Table 23: Global Market Shares of Capsaicin-derived Pain Treatments, by Indication, 2018
    • Table 24: Clinical Trials on Menthol Containing Non-Opioid Pain Therapeutics for Diabetic Neuropathic Pain, Through Nov. 30, 2017
    • Table 25: Global Menthol-containing Pain Treatment Market, by Indication, Through 2024
    • Table 26: Selected Omega-3 Fatty Acid-containing Clinical Trials for Pain Treatment, Through Nov. 30, 2019
    • Table 27: Selected Omega-3 Fatty Acid-containing Clinical Trials for Pain Treatment, Through Nov. 30, 2019
    • Table 28: Global Omega-3 Fatty Acid-containing Pain Treatment Market, by Indication, Through 2024
    • Table 29: Global Market Shares of Omega-3 Fatty Acid-containing Pain Treatments, by Indication, 2018
    • Table 30: U.S. Market for Allergan's Botox, by Treatment Area, 2018
    • Table 31: Selected Botulinum Toxin Clinical Trials for Pain Treatment, Through Nov. 30, 2017
    • Table 32: Global Botulinum Toxin Pain Treatment Market, by Indication, Through 2024
    • Table 33: Global Market for Botulinum Toxin Pain Treatments, by Indication, 2018
    • Table 34: Global Non-opioid Pain Treatment Market, by Therapeutic Application, Through 2024
    • Table 35: Global Market Shares of Non-opioid Pain Treatments, by Therapeutic Application, 2018
    • Table 36: Global Non-opioid Cancer Pain Treatment Market, by Product Segment, Through 2024
    • Table 37: Global Market Shares of Non-opioid Cancer Pain Treatments, by Product Segment, 2018
    • Table 38: Global Market Shares of Non-opioid Cancer Pain Treatments, by Cancer Type, 2018
    • Table 39: Global Non-opioid Neuropathic Pain Treatment Market, by Product Segment, Through 2024
    • Table 40: Global Market Shares of Non-opioid Neuropathic Pain Treatments, by Product Segment, 2018
    • Table 41: Global Market Shares of Non-opioid Neuropathic Pain Treatments, by Disease/Disorder Type, 2018
    • Table 42: Global Non-opioid Orthopedic/Musculoskeletal Pain Treatment Market, by Product Segment, Through 2024
    • Table 43: Global Market Shares of Non-opioid Orthopedic/Musculoskeletal Pain Treatments, by Product Segment, 2018
    • Table 44: Global Market Shares of Non-opioid Orthopedic/Musculoskeletal Pain Treatments, by Disease/Disorder Type, 2018
    • Table 45: Global Market for Other Non-opioid Pain Treatments, by Product Segment, Through 2024
    • Table 46: Global Market Shares of Other Non-opioid Pain Treatments, by Product Segment, 2018
    • Table 47: Global Market Shares of Other Non-opioid Pain Treatments, by Disease/Disorder Type, 2018
    • Table 48: Global Non-opioid Pain Treatment Market, by Region, Through 2024
    • Table 49: Global Market Shares of Non-opioid Pain Treatments, by Region, 2018
    • Table 50: Regional Grouping: Countries, by Region
    • Table 51: North American Non-opioid Pain Treatment Market, by Country, Through 2024
    • Table 52: EMEA Non-opioid Pain Treatment Market, by Country, Through 2024
    • Table 53: Asia-Pacific Non-opioid Pain Treatment Market, by Country, Through 2024
    • Table 54: Latin American Non-opioid Pain Treatment Market, by Country, Through 2024
    • Table 55: U.S. Patents Related to Medical Cannabis, by Type, Through 2018
    • Table 56: U.S. Patents on Medical Cannabis Technologies, by Type, Through 2018
    • Table 57: Notable U.S. Patents Related to Medical Cannabis, by Company, Through 2018
    • Table 58: List of U.S. Patents Related to Medical Cannabis, July 2017-Nov. 2017
    • Table 59: Notable Developments in Non-opioid Pain Relief, 2000-2017
    • Table 60: Glossary of Terms Used in Non-opioid Pain Treatment
    • Table 61: Global Pain Societies and Organizations
    • Table 62: Report Sources

List of Figures

  • Summary Figure: Global Market for Non-opioid Pain Treatments, by Product Segment, 2018-2024
    • Figure 1: Non-opioid Pain Management Market Drivers and Restraints
    • Figure 2: Pain Management Techniques
    • Figure 3: Total Hospice Patients Served, by Year, 2009-2014
    • Figure 4: Distribution of Causes of Mortality and Potential Need for Palliative Care, 2018
    • Figure 5: Global Population, by Country/Region, 2019 and 2024
    • Figure 6: Global Population Age 65+, by Country/Region, 2019 and 2024
    • Figure 7: Global Life Expectancy at Birth, by Country/Region, 1980, 2010 and 2020 Projections (Both Genders Combined)
    • Figure 8: Global Non-opioid Pain Treatment Market, by Product Segment, 2018-2024
    • Figure 9: Global Market Shares of Non-opioid Pain Treatments, by Product Segment, 2018
    • Figure 10: Global Market Shares of Medical Cannabis: Pain vs. All Other Uses, 2018
    • Figure 11: Global Medical Cannabis Pain Treatment Market, by Indication, 2018-2024
    • Figure 12: Global Market Shares of Medical Cannabis Pain Treatments, by Indication, 2018
    • Figure 13: Global Capsaicin-derived Pain Treatment Market, by Indication, 2018-2024
    • Figure 14: Global Market Shares of Capsaicin-derived Pain Treatments, by Indication, 2018
    • Figure 15: Global Menthol-containing Pain Treatment Market, by Indication, 2018-2024
    • Figure 16: Global Market Shares of Menthol-containing Pain Treatments, by Indication, 2018
    • Figure 17: Global Omega-3 Fatty Acid-containing Pain Treatment Market, by Indication, 2018-2024
    • Figure 18: Global Market Shares of Omega-3 Fatty Acid-containing Pain Treatments, by Indication, 2018
    • Figure 19: Global Botulinum Toxin Pain Treatment Market, by Indication, 2018-2024
    • Figure 20: Global Market Shares of Botulinum Toxin Pain Treatments, by Indication, 2018
    • Figure 21: Global Non-opioid Pain Treatment Market, by Therapeutic Application, 2019-2024
    • Figure 22: Global Market Shares of Non-opioid Pain Treatments, by Therapeutic Application, 2018
    • Figure 23: Global Non-opioid Cancer Pain Treatment Market, by Product Segment, 2018-2024
    • Figure 24: Global Market Shares of Non-opioid Cancer Pain Treatments, by Product Segment, 2018
    • Figure 25: Global Market Shares of Non-opioid Cancer Pain Treatments, by Cancer Type, 2018
    • Figure 26: Global Non-opioid Neuropathic Pain Treatment Market, by Product Segment, 2018-2024
    • Figure 27: Global Market Shares of Non-opioid Neuropathic Pain Treatments, by Product Segment, 2018
    • Figure 28: Global Market Shares of Non-opioid Neuropathic Pain Treatments, by Disease/Disorder Type, 2018
    • Figure 29: Global Non-opioid Orthopedic/Musculoskeletal Pain Treatment Market, by Product Segment, 2018-2024
    • Figure 30: Global Market Shares of Non-opioid Orthopedic/Musculoskeletal Pain Treatments, by Product Segment, 2018
    • Figure 31: Global Market Shares of Non-opioid Orthopedic/Musculoskeletal Pain Treatments, by Disease/Disorder Type, 2018
    • Figure 32: Global Market for Other Non-opioid Pain Treatments, by Product Segment, 2018-2024
    • Figure 33: Global Market Shares of Other Non-opioid Pain Treatments, by Product Segment, 2018
    • Figure 34: Global Market Shares of Other Non-opioid Pain Treatments, by Disease/Disorder Type, 2018
    • Figure 35: Global Non-opioid Pain Treatment Market, by Region, 2018-2024
    • Figure 36: Global Market Shares of Non-opioid Pain Treatments, by Region, 2018
    • Figure 37: North American Non-opioid Pain Treatment Market, by Country, 2018-2024
    • Figure 38: North American Market Shares of Alternative Non-opioid Pain Treatments, by Country, 2018
    • Figure 39: Canadian Market Shares of Alternative Non-opioid Pain Treatments, by Product Segment, 2018
    • Figure 40: Canadian Market Shares of Alternative Non-opioid Pain Treatments, by Application, 2018
    • Figure 41: U.S. Market Shares of Alternative Non-opioid Pain Treatments, by Product Segment, 2018
    • Figure 42: U.S. Market Shares of Alternative Non-opioid Pain Treatments, by Application, 2018
    • Figure 43: EMEA Non-opioid Pain Treatment Market, by Country, 2018-2024
    • Figure 44: EMEA Market Shares of Alternative Non-opioid Pain Treatments, by Country, 2018
    • Figure 45: French Market Shares of Alternative Non-opioid Pain Treatments, by Product Segment, 2018
    • Figure 46: French Market Shares of Alternative Non-opioid Pain Treatments, by Application, 2018
    • Figure 47: German Market Shares of Alternative Non-opioid Pain Treatments, by Product Segment, 2018
    • Figure 48: German Market Shares of Alternative Non-opioid Pain Treatments, by Application, 2018
    • Figure 49: Italian Market Shares of Alternative Non-opioid Pain Treatments, by Product Segment, 2018
    • Figure 50: Italian Market Shares of Alternative Non-opioid Pain Treatments, by Application, 2018
    • Figure 51: Russian Market Shares of Alternative Non-opioid Pain Treatments, by Product Segment, 2018
    • Figure 52: Russian Market Shares of Alternative Non-opioid Pain Treatments, by Application, 2018
    • Figure 53: Spanish Market Shares of Alternative Non-opioid Pain Treatments, by Product Segment, 2018
    • Figure 54: Spanish Market Shares of Alternative Non-opioid Pain Treatments, by Application, 2018
    • Figure 55: U.K. Market Shares of Alternative Non-opioid Pain Treatments, by Product Segment, 2018
    • Figure 56: U.K. Market Shares of Alternative Non-opioid Pain Treatments, by Application, 2018
    • Figure 57: Asia-Pacific Non-opioid Pain Treatment Market, by Country, 2018-2024
    • Figure 58: Asia-Pacific Market Shares of Alternative Non-opioid Pain Treatments, by Country, 2018
    • Figure 59: Australia/New Zealand's Market Shares of Alternative Non-opioid Pain Treatments, by Product Segment, 2018
    • Figure 60: Australia/New Zealand's Market Shares of Alternative Non-opioid Pain Treatments, by Application, 2018
    • Figure 61: Chinese Market Shares of Alternative Non-opioid Pain Treatments, by Product Segment, 2018
    • Figure 62: Chinese Market Shares of Alternative Non-opioid Pain Treatments, by Application, 2018
    • Figure 63: Japanese Market Shares of Alternative Non-opioid Pain Treatments, by Product Segment, 2018
    • Figure 64: Japanese Market Shares of Alternative Non-opioid Pain Treatments, by Application, 2018
    • Figure 65: Latin American Non-opioid Pain Treatment Market, by Country, 2018-2024
    • Figure 66: Latin American Market Shares of Alternative Non-opioid Pain Treatments, by Country, 2018
    • Figure 67: Argentinean Market Shares of Alternative Non-opioid Pain Treatments, by Product Segment, 2018
    • Figure 68: Argentinean Market Shares of Alternative Non-opioid Pain Treatments, by Application, 2018
    • Figure 69: Brazilian Market Shares of Alternative Non-opioid Pain Treatments, by Product Segment, 2018
    • Figure 70: Brazilian Market Shares of Alternative Non-opioid Pain Treatments, by Application, 2018
    • Figure 71: Mexican Market Shares of Alternative Non-opioid Pain Treatments, by Product Segment, 2018
    • Figure 72: Mexican Market Shares of Alternative Non-opioid Pain Treatments, by Application, 2018
    • Figure 73: Total U.S. Patents on Non-opioid Pain Treatments, by Type, Through 2018
    • Figure 74: Shares of U.S. Patents Related to Medical Cannabis, by Type, Through 2018
    • Figure 75: Shares of U.S. Patents on Medical Cannabis Technologies, by Type, Through 2018
目次
Product Code: HLC206B

Report Highlights:

The global market for non-opioid pain treatments should grow from $13.8 billion in 2019 to $31.8 billion by 2024 at a compound annual growth rate (CAGR) of 18.3% for the period of 2019-2024.

Medical cannabis non-opioid pain treatments market should grow from $9.4 billion in 2019 to reach $22.2 billion by 2024 at a CAGR of 18.8% for the period of 2019-2024.

Capsaicin-derived non-opioid pain treatments market should grow from $438.0 million in 2019 to reach $1.1 billion by 2024 at a CAGR of 20.4% for the period of 2019-2024.

Report Scope:

This BCC Research report is designed to be a helpful business tool that will provide a thorough evaluation of the markets for pain management. The geographical scope of this study is global. This study addresses acute versus chronic pain, treatments and regulatory issues facing healthcare workers. Also provided is detailed information based on product categories, use of products, forecasts and competitive analyses.

The report identifies five general product segments for Non-opioid treatment of pain -

  • Medical cannabis treatments.
  • Capsaicin-derived treatments.
  • Menthol-containing treatments.
  • Omega 3 fatty acid-containing treatments.
  • Botulinum toxins.

Within the segment several sub-segments are discussed as they pertain to each product segment; diseases or disorders are the basis for these sub-segments, including -

  • Arthritis.
  • Cancer-brain, breast, colorectal, leukemia/lymphoma, melanoma, prostate, others.
  • Dental.
  • Epilepsy.
  • Fibromyalgia.
  • Migraine.
  • Multiple sclerosis.
  • Surgical.

A regional analysis of these product segments is also provided, including the specific countries listed below and including countries not listed as a "rest of the world" market.

  • Argentina.
  • Australia/New Zealand.
  • Brazil.
  • Canada.
  • China.
  • France.
  • Germany.
  • Italy.
  • Japan.
  • Mexico.
  • Russia.
  • Spain.
  • United Kingdom.
  • United States.

Each market segment provides detailed information based on product categories, product use, current market value and forecasts.

Not covered in the report are drugs or devices that are considered "conventional" in professional treatment guidelines that are due to either controversial issues such as those with medical cannabis or those that are not commonly prescribed or recommended due to a lack of clinical data, education or other factors.

Report Includes:

  • 44 data tables and 19 additional tables
  • An overview of the global market for Non-opioid pain treatments
  • Analyses of global market trends, with data from 2018 and 2019, and projections of compound annual growth rates (CAGRs) through 2024
  • Description of products included in this market, and a detailed analysis of the markets and market opportunities
  • Information on significant products categories, issues and trends, market influences, regulatory issues and other information affecting the pain management industry
  • Briefing about major drivers and regional dynamics of the market and current trends within the industry
  • Comprehensive profiles of major vendors in the market, including Allergan PLC, Canopy Growth Corp., Medical Marijuana Inc., Panag Pharma Inc., and Tilray

Table of Contents

Chapter 1: Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2: Summary and Highlights

  • Market Overview
  • Drivers and Restraints

Chapter 3: Market Overview and Background

  • Definition of Pain and Nociception
  • Pain
  • Nociception
  • History of Pain and Pain Treatment
  • Types of Pain
  • Acute Pain
  • Chronic Pain
  • Physiological Pain Classifications
  • How Pain is Diagnosed
  • How Pain is Treated
  • Opioid vs. Non-opioid Pain Control
  • Opioids, also Known as Narcotic Analgesics
  • Full and Partial Agonists
  • Agonist-Antagonists
  • Risk and Complications in Opioid Pain Treatment
  • Addiction and Abuse
  • Challenges of Breakthrough Pain Control
  • Alternative Methods of Pain Management
  • Alternative Non-opioid Therapies for Treating Pain
  • Medical Cannabis
  • Capsaicin-derived Compound
  • Menthol-containing Compound
  • Omega 3 Fatty Acid-containing Supplements
  • Botulinum Toxins (OnabotulinumtoxinA/RimabotulinumtoxinB)
  • Others
  • Growing Trend in Cannabis Treatment for Pain
  • Adoption of Medical Cannabis: A Global Analysis
  • Laws and Legalization Trends
  • Claims in Effectiveness
  • Potency and Validation Testing Trends
  • Hospice Care
  • Access to Palliative Care Around the World
  • Assessing the Need for Palliative Care
  • Market Influences and Indicators of Growth
  • Demographic Overview
  • Incidence and Prevalence of Conditions with Pain Symptoms

Chapter 4: Market Breakdown by Product Segment

  • Overview
  • Medical Cannabis
  • Capsaicin-derived Therapies
  • Menthol-containing Therapies
  • Omega-3 Fatty Acid-containing Therapies
  • Botulinum Toxin Treatments

Chapter 5: Market Breakdown by Therapeutic Application

  • Overview
  • Alternative Non-opioid Cancer Pain Treatment
  • Alternative Non-opioid Neuropathic Pain Treatment
  • Alternative Non-opioid Orthopedic/Musculoskeletal Pain Treatments
  • Other Alternative Non-Opioid Pain Treatments

Chapter 6: Market Breakdown by Region

  • Overview
  • Regional Groupings
  • North America
  • North America: Pioneer in the Medicinal Cannabis Industry
  • Canada
  • United States
  • EMEA
  • France
  • Germany
  • Italy
  • Russia
  • Spain
  • United Kingdom
  • Asia-Pacific
  • Australia/New Zealand
  • China
  • Japan
  • Latin America
  • Argentina
  • Brazil
  • Mexico

Chapter 7: Patent Analysis

  • Patent Analysis Overview
  • Non-opioid Pain Relief Categories
  • Medical Cannabis
  • Technologies
  • Cannabis Patent Review by Year
  • Patent Review by Company
  • Patent Review by Assignee

Chapter 8: Company Profiles

  • ALLERGAN PLC
  • APHRIA INC.
  • AURORA
  • BEDROCAN
  • CANOPY GROWTH CORP.
  • CARA THERAPEUTICS
  • CENTREXION THERAPEUTICS
  • CHT MEDICAL
  • CRONOS GROUP
  • GW PHARMACEUTICALS
  • MEDICAL MARIJUANA INC.
  • MEDROPHARM GMBH
  • PANAG PHARMA INC.
  • TILRAY
  • US WORLDMEDS LLC
  • VANWAY

Chapter 9: Appendix: Terminology and Sources of Information

Back to Top